Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury

Cardiovascular Research

Volumn 77, Issue 2, 2008, Pages 325-333

  Ruiz Meana, Marisol ^a   Rodríguez Sinovas, Antonio ^a   Cabestrero, Alberto ^a   Boengler, Kerstin ^b   Heusch, Gerd ^b   Garcia Dorado, David ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cardioprotection; Connexins; Gap junctions; Ischaemia; Mitochondria; Myocardial infarction; Reperfusion

Indexed keywords

CONNEXIN 43; REACTIVE OXYGEN METABOLITE;

AGING; CELL DEATH; GAP JUNCTION; HEART ARRHYTHMIA; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MITOCHONDRIAL MEMBRANE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CONNEXIN 43; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIA, HEART; MITOCHONDRIAL PROTEINS; MYOCARDIAL REPERFUSION INJURY;

EID: 38849201088     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvm062     Document Type: Review

References (106)

1. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 2003;83:1359-1400.
2. Sohl G, Willecke K. Gap junctions and the connexin protein family. Cardiovasc Res 2004;62:228-232.
3. Saffitz JE, Laing JG, Yamada KA. Connexin expression and turnover: implications for cardiac excitability. Circ Res 2000;86:723-728.
4. Giepmans BN. Gap junctions and connexin-interacting proteins. Cardiovasc Res 2004;62:233-245.
5. Jalife J, Morley GE, Vaidya D. Connexins and impulse propagation in the mouse heart. J Cardiovasc Electrophysiol 1999;10:1649-1663.
6. Lo CW. Role of gap junctions in cardiac conduction and development: insights from the connexin knockout mice. Circ Res 2000;87:346- 348.
7. Garcia-Dorado D, Rodriguez-Sinovas A, Ruiz-Meana M. Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion. Cardiovasc Res 2004;61:386-401.
8. Rodriguez-Sinovas A, Cabestrero A, Lopez D, Torre I, Morente M, Abellan A et al. The modulatory effects of connexin 43 on cell death/survival beyond cell coupling. Prog Biophys Mol Biol 2007;94:219-232.
9. Cascio WE, Johnson TA, Gettes LS. Electrophysiologic changes in ischemic ventricular myocardium: I. Influence of ionic, metabolic, and energetic changes. J Cardiovasc Electrophysiol 1995;6:1039-1062.
10. Dekker LR, Fiolet JW, VanBavel E, Coronel R, Opthof T, Spaan JA et al. Intracellular Ca2+, intercellular electrical coupling, and mechanical activity in ischemic rabbit papillary muscle. Effects of preconditioning and metabolic blockade. Circ Res 1996;79:237-246.
11. Kleber AG, Riegger CB, Janse MJ. Electrical uncoupling and increase of extracellular resistance after induction of ischemia in isolated, arterially perfused rabbit papillary muscle. Circ Res 1987;61:271-279.
12. Kleber AG. Consequences of acute ischemia for the electrical and mechanical function of the ventricular myocardium. A brief review. Experientia 1990;46:1162-1167.
13. Ehlert FA, Goldberger JJ. Cellular and pathophysiological mechanisms of ventricular arrhythmias in acute ischemia and infarction. Pacing Clin Electrophysiol 1997;20:966-975.
14. Jeyaraman M, Tanguy S, Fandrich RR, Lukas A, Kardami E. Ischemia-induced dephosphorylation of cardiomyocyte connexin-43 is reduced by okadaic acid and calyculin A but not fostriecin. Mol Cell Biochem 2003;242:129-134.
15. Schulz R, Gres P, Skyschally A, Duschin A, Belosjorow S, Konietzka I et al. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. FASEB J 2003;17:1355-1357.
16. Yao JA, Hussain W, Patel P, Peters NS, Boyden PA, Wit AL. Remodeling of gap junctional channel function in epicardial border zone of healing canine infarcts. Circ Res 2003;92:437-443.
17. Zeevi-Levin N, Barac YD, Reisner Y, Reiter I, Yaniv G, Meiry G et al. Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. Cardiovasc Res 2005;66:64-73.
18. Danik SB, Liu F, Zhang J, Suk HJ, Morley GE, Fishman GI et al. Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ Res 2004;95:1035-1041.
19. Moreno AP, Lau AF. Gap junction channel gating modulated through protein phosphorylation. Prog Biophys Mol Biol 2007;94:106-118.
20. Solan JL, Lampe PD. Connexin phosphorylation as a regulatory event linked to gap junction channel assembly. Biochim Biophys Acta 2005;1711:154-163.
21. Schulz R, Heusch G. Connexin 43 and ischemic preconditioning. Cardiovasc Res 2004;62:335-344.
22. Schulz R, Boengler K, Totzeck A, Luo Y, Garcia-Dorado D, Heusch G. Connexin 43 in ischemic pre- and postconditioning. Heart Fail Rev 2007;12:261-266.
23. Harris AL. Connexin channel permeability to cytoplasmic molecules. Prog Biophys Mol Biol 2007;94:120-143.
24. Garcia-Dorado D, Theroux P, Desco M, Solares J, Elizaga J, Fernandez-Aviles F et al. Cell-to-cell interaction: a mechanism to explain wave-front progression of myocardial necrosis. Am J Physiol 1989;256:H1266-H1273.
25. Garcia-Dorado D, Inserte J, Ruiz-Meana M, Gonzalez MA, Solares J, Julia M et al. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 1997;96:3579-3586.
26. Ruiz-Meana M, Garcia-Dorado D, Hofstaetter B, Piper HM, Soler-Soler J. Propagation of cardiomyocyte hypercontracture by passage of Na(+) through gap junctions. Circ Res 1999;85:280-287.
27. Rodriguez-Sinovas A, Garcia-Dorado D, Ruiz-Meana M, Soler-Soler J. Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium. J Physiol 2004;559:245-257.
28. Inserte J, Garcia-Dorado D, Hernando V, Soler-Soler J. Calpain-mediated impairment of Na+/K+-ATPase activity during early reperfusion contributes to cell death after myocardial ischemia. Circ Res 2005;97:465-473.
29. Azzam EI, de Toledo SM, Little JB. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to nonirradiated cells. Proc Natl Acad Sci USA 2001;98:473-478.
30. Cusato K, Bosco A, Rozental R, Guimaraes CA, Reese BE, Linden R et al. Gap junctions mediate bystander cell death in developing retina. J Neurosci 2003;23:6413-6422.
31. Lin JH, Weigel H, Cotrina ML, Liu S, Bueno E, Hansen AJ et al. Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci 1998;1:494-500.
32. Rami A, Volkmann T, Winckler J. Effective reduction of neuronal death by inhibiting gap junctional intercellular communication in a rodent model of global transient cerebral ischemia. Exp Neurol 2001;170:297-304.
33. Rawanduzy A, Hansen A, Hansen TW, Nedergaard M. Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke. J Neurosurg 1997;87:916-920.
34. Blanc EM, Bruce-Keller AJ, Mattson MP. Astrocytic gap junctional communication decreases neuronal vulnerability to oxidative stress-induced disruption of Ca2+ homeostasis and cell death. J Neurochem 1998;70:958-970.
35. Li G, Whittaker P, Yao M, Kloner RA, Przyklenk K. The gap junction uncoupler heptanol abrogates infarct size reduction with preconditioning in mouse hearts. Cardiovasc Pathol 2002;11:158-165.
36. Yasui K, Kada K, Hojo M, Lee JK, Kamiya K, Toyama J et al. Cell-to-cell interaction prevents cell death in cultured neonatal rat ventricular myocytes. Cardiovasc Res 2000;48:68-76.
37. Schafer C, Ladilov Y, Inserte J, Schafer M, Haffner S, Garcia-Dorado D et al. Role of the reverse mode of the Na+/Ca2+ exchanger in reoxygenation-induced cardiomyocyte injury. Cardiovasc Res 2001;51:241-250.
38. Ruiz-Meana M, Garcia-Dorado D, Lane S, Pina P, Inserte J, Mirabet M et al. Persistence of gap junction communication during myocardial ischemia. Am J Physiol Heart Circ Physiol 2001;280:H2563-H2571.
39. Garcia-Dorado D, Rodriguez-Sinovas A, Ruiz-Meana M, Inserte J, Agullo L, Cabestrero A. The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion. Cardiovasc Res 2006;70:274-285.
40. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 1998;38:291-300.
41. Inserte J, Garcia-Dorado D, Ruiz-Meana M, Padilla F, Barrabes JA, Pina P et al. Effect of inhibition of Na(+)/Ca(2+) exchanger at the time of myocardial reperfusion on hypercontracture and cell death. Cardiovasc Res 2002;55:739-748.
42. Argaud L, Gateau-Roesch O, Muntean D, Chalabreysse L, Loufouat J, Robert D et al. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 2005;38:367-374.
43. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc Res 2004;61:372-385.
44. Shanmuganathan S, Hausenloy DJ, Duchen MR, Yellon DM. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol 2005;289:H237-H242.
45. Ruiz-Meana M, Abellan A, Miro-Casas E, Garcia-Dorado D. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca(2+) overloaded cardiac myocytes. Basic Res Cardiol 2007;102:542-552.
46. Kanno S, Kovacs A, Yamada KA, Saffitz JE. Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice. J Am Coll Cardiol 2003;41:681-686.
47. Schwanke U, Konietzka I, Duschin A, Li X, Schulz R, Heusch G. No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol Heart Circ Physiol 2002;283:H1740-H1742.
48. Schwanke U, Li X, Schulz R, Heusch G. No ischemic preconditioning in heterozygous connexin 43-deficient mice - a further in vivo study. Basic Res Cardiol 2003;98:181-182.
49. Padilla F, Garcia-Dorado D, Rodriguez-Sinovas A, Ruiz-Meana M, Inserte J, Soler-Soler J. Protection afforded by ischemic preconditioning is not mediated by effects on cell-to-cell electrical coupling during myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2003;285:H1909-H1916.
50. Li X, Heinzel FR, Boengler K, Schulz R, Heusch G. Role of connexin 43 in ischemic preconditioning does not involve intercellular communication through gap junctions. J Mol Cell Cardiol 2004;36:161-163.
51. Plotkin LI, Bellido T. Bisphosphonate-induced, hemichannel-mediated, anti-apoptosis through the Src/ERK pathway: a gap junction-independent action of connexin43. Cell Commun Adhes 2001;8:377-382.
52. Lin JH, Yang J, Liu S, Takano T, Wang X, Gao Q et al. Connexin mediates gap junction-independent resistance to cellular injury. J Neurosci 2003;23:430-441.
53. Saez JC, Retamal MA, Basilio D, Bukauskas FF, Bennett MV. Connexin-based gap junction hemichannels: gating mechanisms. Biochim Biophys Acta 2005;1711:215-224.
54. John SA, Kondo R, Wang SY, Goldhaber JI, Weiss JN. Connexin-43 hemi-channels opened by metabolic inhibition. J Biol Chem 1999;274:236-240.
55. Shintani-Ishida K, Uemura K, Yoshida K. Hemichannels in cardiomyocytes open transiently during ischemia and contribute to reperfusion injury following brief ischemia. Am J Physiol Heart Circ Physiol 2007;293:H1714- H1720.
56. Sickmann A, Reinders J, Wagner Y, Joppich C, Zahedi R, Meyer HE et al. The proteome of Saccharomyces cerevisiae mitochondria. Proc Natl Acad Sci USA 2003;100:13207-13212.
57. Dang X, Doble BW, Kardami E. The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth. Mol Cell Biochem 2003;242:35-38.
58. Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res 1998;58:5089-5096.
59. Dang X, Jeyaraman M, Kardami E. Regulation of connexin-43-mediated growth inhibition by a phosphorylatable amino-acid is independent of gap junction-forming ability. Mol Cell Biochem 2006;289:201-207.
60. Jiang JX, Gu S. Gap junction- and hemichannel-independent actions of connexins. Biochim Biophys Acta 2005;1711:208-214.
61. Joshi-Mukherjee R, Coombs W, Burrer C, de Mora IA, Delmar M, Taffet SM. Evidence for the presence of a free C-terminal fragment of cx43 in cultured cells. Cell Commun Adhes 2007;14:75-84.
62. Herve JC, Bourmeyster N, Sarrouilhe D. Diversity in protein-protein interactions of connexins: emerging roles. Biochim Biophys Acta 2004;1662:22-41.
63. Boengler K, Dodoni G, Rodriguez-Sinovas A, Cabestrero A, Ruiz-Meana M, Gres P et al. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res 2005;67:234-244.
64. Goubaeva F, Mikami M, Giardina S, Ding B, Abe J, Yang J. Cardiac mitochondrial connexin 43 regulates apoptosis. Biochem Biophys Res Commun 2007;352:97-103.
65. Halestrap AP. Mitochondria and preconditioning: a connexin connection? Circ Res 2006;99:10-12.
66. Taylor SW, Fahy E, Zhang B, Glenn GM, Warnock DE, Wiley S et al. Characterization of the human heart mitochondrial proteome. Nat Biotechnol 2003;21:281-286.
67. Ahram M, Springer DL. Large-scale proteomic analysis of membrane proteins. Expert Rev Proteomics 2004;1:293-302.
68. Jorge I, Casas EM, Villar M, Ortega-Perez I, Lopez-Ferrer D, Martinez-Ruiz A et al. High-sensitivity analysis of specific peptides in complex samples by selected MS/MS ion monitoring and linear ion trap mass spectrometry: application to biological studies. J Mass Spectrom 2007;42:1391-1403.
69. Rodriguez-Sinovas A, Boengler K, Cabestrero A, Gres P, Morente M, Ruiz-Meana M et al. Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res 2006;99:93-101.
70. Rehling P, Brandner K, Pfanner N. Mitochondrial import and the twin-pore translocase. Nat Rev Mol Cell Biol 2004;5:519-530.
71. Endo H, Saito A, Chan PH. Mitochondrial translocation of p53 underlies the selective death of hippocampal CA1 neurons after global cerebral ischaemia. Biochem Soc Trans 2006;34:1283-1286.
72. Heinzel FR, Luo Y, Li X, Boengler K, Buechert A, Garcia-Dorado D et al. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res 2005;97:583-586.
73. Lim KH, Javadov SA, Das M, Clarke SJ, Suleiman MS, Halestrap AP. The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J Physiol 2002;545:961-974.
74. Schulz R, Cohen MV, Behrends M, Downey JM, Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc Res 2001;52:181-198.
75. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003;83:1113-1151.
76. Ardehali H, O'Rourke B. Mitochondrial K(ATP) channels in cell survival and death. J Mol Cell Cardiol 2005;39:7-16.
77. Cohen MV, Yang XM, Liu GS, Heusch G, Downey JM. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res 2001;89:273-278.
78. Hanley PJ, Mickel M, Loffler M, Brandt U, Daut J. K(ATP) channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol 2002;542:735-741.
79. Grover GJ, Murray HN, Baird AJ, Dzwonczyk S. The KATP blocker sodium 5-hydroxydecanoate does not abolish preconditioning in isolated rat hearts. Eur J Pharmacol 1995;277:271-274.
80. Pain T, Yang XM, Critz SD, Yue Y, Nakano A, Liu GS et al. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res 2000;87:460-466.
81. Heusch G, Buchert A, Feldhaus S, Schulz R. No loss of cardioprotection by postconditioning in connexin 43-deficient mice. Basic Res Cardiol 2006;101:354-356.
82. Boengler K, Ruiz-Meana M, Miro-Casas E, Cabestrero A, Rodriguez-Sinovas A, Dodoni G et al. Connexin 43 controls mitochondrial respiration. Circulation 2006;114(Suppl. II):243 (Abstract).
83. Miro-Casas E, Ruiz-Meana M, Agullo E, Torre I, Cabestrero A, Rodriguez-Sinovas A et al. Connexin43 in the inner mitochondrial membrane of cardiomyocytes forms hemichannels that contribute to matrix volume regulation. Circulation 2007;116: II_67.
84. Ping P, Song C, Zhang J, Guo Y, Cao X, Li RC et al. Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection. J Clin Invest 2002;109:499-507.
85. Barker RJ, Price RL, Gourdie RG. Increased association of ZO-1 with connexin43 during remodeling of cardiac gap junctions. Circ Res 2002;90:317-324.
86. Giepmans BN, Verlaan I, Hengeveld T, Janssen H, Calafat J, Falk MM et al. Gap junction protein connexin-43 interacts directly with microtubules. Curr Biol 2001;11:1364-1368.
87. Chanson M, Kotsias BA, Peracchia C, O'Grady SM. Interactions of connexins with other membrane channels and transporters. Prog Biophys Mol Biol 2007;94:233-244.
88. Nicchia GP, Srinivas M, Li W, Brosnan CF, Frigeri A, Spray DC. New possible roles for aquaporin-4 in astrocytes: cell cytoskeleton and functional relationship with connexin43. FASEB J 2005;19:1674-1676.
89. Hausenloy D, Wynne A, Duchen M, Yellon D. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 2004;109:1714-1717.
90. Paul DL, Ebihara L, Takemoto LJ, Swenson KI, Goodenough DA. Connexin46, a novel lens gap junction protein, induces voltage-gated currents in nonjunctional plasma membrane of Xenopus oocytes. J Cell Biol 1991;115:1077-1089.
91. Bukauskas FF, Bukauskiene A, Verselis VK. Conductance and permeability of the residual state of connexin43 gap junction channels. J Gen Physiol 2002;119:171-185.
92. Seki A, Duffy HS, Coombs W, Spray DC, Taffet SM, Delmar M. Modifications in the biophysical properties of connexin43 channels by a peptide of the cytoplasmic loop region. Circ Res 2004;95:e22-e28.
93. Kostin S. Zonula occludens-1 and connexin 43 expression in the failing human heart. J Cell Mol Med 2007;11:892-895.
94. Sheeran FL, Pepe S. Energy deficiency in the failing heart: linking increased reactive oxygen species and disruption of oxidative phosphorylation rate. Biochim Biophys Acta 2006;1757:543-552.
95. Boengler K, Konietzka I, Buechert A, Heinen Y, Garcia-Dorado D, Heusch G et al. Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. Am J Physiol Heart Circ Physiol 2007;292:H1764-H1769.
96. Rohrbach S, Niemann B, Abushouk AM, Holtz J. Caloric restriction and mitochondrial function in the ageing myocardium. Exp Gerontol 2006;41:525-531.
97. Chen M, Jones DL. Age- and myopathy-dependent changes in connexins of normal and cardiomyopathic Syrian hamster ventricular myocardium. Can J Physiol Pharmacol 2000;78:669-678.
98. Li H, Brodsky S, Kumari S, Valiunas V, Brink P, Kaide J et al. Paradoxical overexpression and translocation of connexin43 in homocysteine-treated endothelial cells. Am J Physiol Heart Circ Physiol 2002;282:H2124-H2133.
99. Kutschera U, Niklas KJ. Endosymbiosis, cell evolution, and speciation. Theory Biosci 2005;124:1-24.
100. van der Heyden MA, van Eijk M, Wilders R, de Bakker JM, Opthof T. Connexin43 orthologues in vertebrates: phylogeny from fish to man. Dev Genes Evol 2004;214:261-266.
101. Phelan P. Gap junction communication in invertebrates: the innexin gene family. In: Peracchia C, ed. Gap Junctions Molecular Basis of Cell Communication in Health and Disease. San Diego: Academic Press; 2000. 389-422.
102. Panchin YV. Evolution of gap junction proteins - the pannexin alternative. J Exp Biol 2005;208:1415-1419.
103. Minners J, Lacerda L, Yellon DM, Opie LH, McLeod CJ, Sack MN. Diazoxide-induced respiratory inhibition - a putative mitochondrial K(ATP) channel independent mechanism of pharmacological preconditioning. Mol Cell Biochem 2007;294:11-18.
104. Brennan JP, Southworth R, Medina RA, Davidson SM, Duchen MR, Shattock MJ. Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation. Cardiovasc Res 2006;72:313-321.
105. Carroll R, Gant VA, Yellon DM. Mitochondrial K(ATP) channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation. Cardiovasc Res 2001;51:691-700.
106. Lim KH, Javadov SA, Das M, Clarke SJ, Suleiman MS, Halestrap AP. The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J Physiol 2002;545:961-974.